Miriam Mikhail-Lette, Lisbeth Cordero, Yolande Lievens, Akram Al-Ibraheem, Jean-Luc Urbain, Bhishamjit Chera, Kristoff Muylle, Aude Vaandering, Arthur Accioly Rosa, Juliano Julio Cerci, Mike Sathekge, Minjmaa Minjgee, Erdenekhuu Nansalmaa, Sereegotov Erdenechimeg, Rolando Loría Ruíz, Andrew Scott, Diana Paez, Francesco Giammarile, Anna Veduta, Erika Minoshima, Shrikant Vichare, May Abdel-Wahab
BACKGROUND: For cancer patient populations worldwide, the synchronous scale-up of diagnostics and treatments yields meaningful gains in survival and quality of life. Among advanced cancer therapies, radiotherapy (RT) and theranostics are key to achieving practical, high-quality, and personalized precision medicine - targeting disease manifestations of individual patients and broad populations, alike. Aiming to learn from one another across different world regions, the six country vignettes presented here depict both challenges and victories in de novo establishment or improvement of RT and theranostics infrastructure...
March 29, 2024: Journal of Cancer Policy